This report developed by UNAIDS and the United for Global Mental Health reviews and maps Global Fund investments in priority HIV and TB comorbidities in Grant Cycle 7 (GC7), including key ...
Definium Therapeutics, Inc. ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of ...
Low-dose opioid therapy provides stable, long-term symptom control and dose stability for patients with augmented restless legs syndrome.
Seaport presents new meta-analysis examining the impact of clinical trial design factors on placebo response in generalized anxiety disorder trials ...
Abstract: Anxiety disorders are a growing concern, but reliable tools for accurate diagnosis and monitoring are limited. Traditional methods of assessment often fail to integrate personalized, ...
Objective To identify whether socioeconomic deprivation is associated with worse health-related quality of life (HR-QoL), anxiety and depression following liver transplantation. Design Cross-sectional ...
Accessibility to cognitive behavioral therapy (CBT) is a barrier to use due to a lack of trained providers and the burden of in-person treatment. A randomized trial showed that a smartphone-delivered ...
Prenatal lead exposure increases risk for major depressive disorder and anxiety symptoms later in life. Individuals with prenatal lead exposure are at higher risk of developing major depressive ...
MRI scans reveal that people who lose their sense of smell after COVID-19 show measurable changes in brain regions tied to emotion and sensory processing, offering new clues to the lingering effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results